Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy

Abstract Background Hepatitis B virus (HBV) reactivation (HBVr) is a major concern for hepatocellular carcinoma (HCC) patients undergoing hepatic arterial infusion chemotherapy (HAIC) using mFOLFOX6 regimen. There is insufficient evidence to support the routine use of HAIC combined with immunotherap...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lijie Zhang, Yiming Liu, Songlin Song, Joyman Makamure, Heshui Shi, Chuansheng Zheng, Bin Liang
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-04-01
Col·lecció:	Infectious Agents and Cancer
Matèries:	Hepatic arterial infusion Immunotherapy Hepatocellular carcinoma Hepatitis B virus Reactivation
Accés en línia:	https://doi.org/10.1186/s13027-024-00574-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!